OpenAlex
PricingAboutJobs
Log inGet started
Work

Phase II trial of weekly alternating sequential BIBF 1120 and afatinib for advanced colorectal cancer.

PubMed

Year: 2011
Type: article
Study design: Clinical Trial
Source: PubMed
Authors: Olivier Bouche, Frederique Maindrault-Goebel, Michel Ducreux, Gerard Lledo, Thierry Andre, Peter Stopfer, Nadia Amellal, Michael Merger, Aimery De Gramont
Institution: Centre Hospitalier Universitaire de Reims
Language: English

Topic: Colorectal Cancer Treatments and Studies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: nintedanib, afatinib, advanced colorectal cancer, angiokinase inhibitors, weekly dosing, objective response rate, adverse events, pharmacokinetics, progression-free survival
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2182450251
FWCI: 2.251
Cites: 56
Cited by: 44
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security